Quantitative electron microscopic autoradiography was used for comparing the binding of labeled somatostatin-14 (S-14) and somatostatin-28 (S-28) to islet cells. Monolayer cultures of rat islet cells were incubated with or 
Introduction
Somatostatin-14 (S-14)' and its NH2-terminally extended form, somatostatin-28 (S-28) are the two principal bioactive species of mammalian somatostatin (1). The two forms have evolved from separate genes in lower vertebrates (2, 3) to a single mammalian gene (4, 5) encoding for a common precursor (6, 7) that is differentially processed to yield characteristic, tissue-specific ratios of S-14/S-28 in different populations of body somatostatin cells (8) . Although the two peptides act in general on common target cells, they exhibit widely different potencies for receptor binding and biological effect, suggesting that their actions may be mediated through separate receptors or via differential modulation of post receptor events (9, 10) . In the case of the pancreas, both S-14 and S-28 are present in islet D cells (1 1, 12). Synthetic S-28 has been reported to be 10-fold more potent than S-14 for inhibiting insulin secretion in vitro (13). Conversely, glucagon suppression by A cells has been shown to be 10 times more sensitive to S-14 than to S-28 (13). This suggests an insulin-selective action of S-28 and a glucagon-selective action of S-14. Using the technique of quantitative electron microscopic autoradiography for visualizing specific binding sites on individual islet cells, we have previously reported preferential binding of labeled S-14 to A cells (14) . We have now compared the binding of both labeled S-14 and S-28 on islet cells and report a preferential association of S-28 binding sites with B cells.
Methods
Islet cell cultures. Monolayer cultures ofpancreatic islet cells from 3-d old Wistar rats were established in 35-mm plastic petri dishes and used on day 6 (14) . The culture medium (DMEM-NCS) consisted of Dulbecco modified Eagle's minimum essential medium with Earle's salt base, supplemented with 10% heat-inactivated newborn calf serum, penicillin (100 U/ml), streptomycin (100 Ag/ml), and fungizone (0.25 ug/ml). The glucose concentration in the medium was 16 Since mammalian islet D cells synthesize predominantly S-14 and contain only trace quantities of S-28, the functional significance of a rich concentration of islet S-28 receptors requires clarification (11, 12) . In lower vertebrates, e.g., anglerfish, a molecule homologous to mammalian S-28 is expressed as the product of a separate gene (distinct from that of S-14) in a subpopulation of islet D cells (23) . With the apparent loss of the S-28-related somatostatin gene (4, 5) , and the corresponding S-28-specific islet D cells in mammalian islets (12) , it could be argued that intraislet S-28 in mammals subserves a minor regulatory role and that the S-28-specific binding sites that we have discovered are vestigial. On the other hand, these sites may interact with extra islet S-28 delivered via the circulation. The largest collection of S-28-producing cells in the body resides in the gut from where S-28 is preferentially released into the blood stream postprandially (8, 12, 24) . It is conceivable that these postprandial surges of circulating S-28 of gut origin modulate, via an endocrine mechanism, the insulin response of the meal-stimulated B cell. The B cells, situated in the core of the islet are the first to receive arterial blood and thus ideally suited for rapid and specific interaction with blood-borne S-28 (25) . Islet D cells with their rich content of S-14 would then be principally involved in the paracrine regulation of glucagon production by A cells, a possibility strengthened by the well known tendency of the A and D cells to be anatomically juxtaposed, both naturally in vivo (25) 
